RANK-dependent autosomal recessive osteopetrosis

Characterization of five new cases with novel mutations

Alessandra Pangrazio, Barbara Cassani, Matteo M Guerrini, Julie C Crockett, Veronica Marrella, Luca Zammataro, Dario Strina, Ansgar Schulz, Claire Schlack, Uwe Kornak, David J Mellis, Angela Duthie, Miep H Helfrich, Anne Durandy, Despina Moshous, Ashok Vellodi, Robert Chiesa, Paul Veys, Nadia Lo Iacono, Paolo Vezzoni & 3 others Alain Fischer, Anna Villa, Cristina Sobacchi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Autosomal recessive osteopetrosis (ARO) is a genetically heterogeneous disorder attributed to reduced bone resorption by osteoclasts. Most human AROs are classified as osteoclast rich, but recently two subsets of osteoclast-poor ARO have been recognized as caused by defects in either TNFSF11 or TNFRSF11A genes, coding the RANKL and RANK proteins, respectively. The RANKL/RANK axis drives osteoclast differentiation and also plays a role in the immune system. In fact, we have recently reported that mutations in the TNFRSF11A gene lead to osteoclast-poor osteopetrosis associated with hypogammaglobulinemia. Here we present the characterization of five additional unpublished patients from four unrelated families in which we found five novel mutations in the TNFRSF11A gene, including two missense and two nonsense mutations and a single-nucleotide insertion. Immunological investigation in three of them showed that the previously described defect in the B cell compartment was present only in some patients and that its severity seemed to increase with age and the progression of the disease. HSCT performed in all five patients almost completely cured the disease even when carried out in late infancy. Hypercalcemia was the most important posttransplant complication. Overall, our results further underline the heterogeneity of human ARO also deriving from the interplay between bone and the immune system, and highlight the prognostic and therapeutic implications of the molecular diagnosis. © 2012 American Society for Bone and Mineral Research.

Original languageEnglish
Pages (from-to)342-351
Number of pages10
JournalJournal of Bone and Mineral Research
Volume27
Issue number2
Early online date9 Nov 2011
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Osteopetrosis
Osteoclasts
Mutation
Immune System
Receptor Activator of Nuclear Factor-kappa B
RANK Ligand
Genes
Nonsense Codon
Hypercalcemia
Bone Resorption
Disease Progression
B-Lymphocytes
Nucleotides
Bone and Bones

Keywords

  • osteoperosis
  • rank
  • immune system
  • transplantaion
  • hypercalcaemia

Cite this

Pangrazio, A., Cassani, B., Guerrini, M. M., Crockett, J. C., Marrella, V., Zammataro, L., ... Sobacchi, C. (2012). RANK-dependent autosomal recessive osteopetrosis: Characterization of five new cases with novel mutations. Journal of Bone and Mineral Research, 27(2), 342-351. https://doi.org/10.1002/jbmr.559

RANK-dependent autosomal recessive osteopetrosis : Characterization of five new cases with novel mutations. / Pangrazio, Alessandra; Cassani, Barbara; Guerrini, Matteo M; Crockett, Julie C; Marrella, Veronica; Zammataro, Luca; Strina, Dario; Schulz, Ansgar; Schlack, Claire; Kornak, Uwe; Mellis, David J; Duthie, Angela; Helfrich, Miep H; Durandy, Anne; Moshous, Despina; Vellodi, Ashok; Chiesa, Robert; Veys, Paul; Iacono, Nadia Lo; Vezzoni, Paolo; Fischer, Alain; Villa, Anna; Sobacchi, Cristina.

In: Journal of Bone and Mineral Research, Vol. 27, No. 2, 02.2012, p. 342-351.

Research output: Contribution to journalArticle

Pangrazio, A, Cassani, B, Guerrini, MM, Crockett, JC, Marrella, V, Zammataro, L, Strina, D, Schulz, A, Schlack, C, Kornak, U, Mellis, DJ, Duthie, A, Helfrich, MH, Durandy, A, Moshous, D, Vellodi, A, Chiesa, R, Veys, P, Iacono, NL, Vezzoni, P, Fischer, A, Villa, A & Sobacchi, C 2012, 'RANK-dependent autosomal recessive osteopetrosis: Characterization of five new cases with novel mutations', Journal of Bone and Mineral Research, vol. 27, no. 2, pp. 342-351. https://doi.org/10.1002/jbmr.559
Pangrazio, Alessandra ; Cassani, Barbara ; Guerrini, Matteo M ; Crockett, Julie C ; Marrella, Veronica ; Zammataro, Luca ; Strina, Dario ; Schulz, Ansgar ; Schlack, Claire ; Kornak, Uwe ; Mellis, David J ; Duthie, Angela ; Helfrich, Miep H ; Durandy, Anne ; Moshous, Despina ; Vellodi, Ashok ; Chiesa, Robert ; Veys, Paul ; Iacono, Nadia Lo ; Vezzoni, Paolo ; Fischer, Alain ; Villa, Anna ; Sobacchi, Cristina. / RANK-dependent autosomal recessive osteopetrosis : Characterization of five new cases with novel mutations. In: Journal of Bone and Mineral Research. 2012 ; Vol. 27, No. 2. pp. 342-351.
@article{415a9d4da81f45adbcd939f4d475f0f4,
title = "RANK-dependent autosomal recessive osteopetrosis: Characterization of five new cases with novel mutations",
abstract = "Autosomal recessive osteopetrosis (ARO) is a genetically heterogeneous disorder attributed to reduced bone resorption by osteoclasts. Most human AROs are classified as osteoclast rich, but recently two subsets of osteoclast-poor ARO have been recognized as caused by defects in either TNFSF11 or TNFRSF11A genes, coding the RANKL and RANK proteins, respectively. The RANKL/RANK axis drives osteoclast differentiation and also plays a role in the immune system. In fact, we have recently reported that mutations in the TNFRSF11A gene lead to osteoclast-poor osteopetrosis associated with hypogammaglobulinemia. Here we present the characterization of five additional unpublished patients from four unrelated families in which we found five novel mutations in the TNFRSF11A gene, including two missense and two nonsense mutations and a single-nucleotide insertion. Immunological investigation in three of them showed that the previously described defect in the B cell compartment was present only in some patients and that its severity seemed to increase with age and the progression of the disease. HSCT performed in all five patients almost completely cured the disease even when carried out in late infancy. Hypercalcemia was the most important posttransplant complication. Overall, our results further underline the heterogeneity of human ARO also deriving from the interplay between bone and the immune system, and highlight the prognostic and therapeutic implications of the molecular diagnosis. {\circledC} 2012 American Society for Bone and Mineral Research.",
keywords = "osteoperosis, rank, immune system, transplantaion, hypercalcaemia",
author = "Alessandra Pangrazio and Barbara Cassani and Guerrini, {Matteo M} and Crockett, {Julie C} and Veronica Marrella and Luca Zammataro and Dario Strina and Ansgar Schulz and Claire Schlack and Uwe Kornak and Mellis, {David J} and Angela Duthie and Helfrich, {Miep H} and Anne Durandy and Despina Moshous and Ashok Vellodi and Robert Chiesa and Paul Veys and Iacono, {Nadia Lo} and Paolo Vezzoni and Alain Fischer and Anna Villa and Cristina Sobacchi",
note = "PMID: 22271396 [PubMed - indexed for MEDLINE] PMCID: PMC3306792 Free PMC Article",
year = "2012",
month = "2",
doi = "10.1002/jbmr.559",
language = "English",
volume = "27",
pages = "342--351",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "WILEY-BLACKWELL",
number = "2",

}

TY - JOUR

T1 - RANK-dependent autosomal recessive osteopetrosis

T2 - Characterization of five new cases with novel mutations

AU - Pangrazio, Alessandra

AU - Cassani, Barbara

AU - Guerrini, Matteo M

AU - Crockett, Julie C

AU - Marrella, Veronica

AU - Zammataro, Luca

AU - Strina, Dario

AU - Schulz, Ansgar

AU - Schlack, Claire

AU - Kornak, Uwe

AU - Mellis, David J

AU - Duthie, Angela

AU - Helfrich, Miep H

AU - Durandy, Anne

AU - Moshous, Despina

AU - Vellodi, Ashok

AU - Chiesa, Robert

AU - Veys, Paul

AU - Iacono, Nadia Lo

AU - Vezzoni, Paolo

AU - Fischer, Alain

AU - Villa, Anna

AU - Sobacchi, Cristina

N1 - PMID: 22271396 [PubMed - indexed for MEDLINE] PMCID: PMC3306792 Free PMC Article

PY - 2012/2

Y1 - 2012/2

N2 - Autosomal recessive osteopetrosis (ARO) is a genetically heterogeneous disorder attributed to reduced bone resorption by osteoclasts. Most human AROs are classified as osteoclast rich, but recently two subsets of osteoclast-poor ARO have been recognized as caused by defects in either TNFSF11 or TNFRSF11A genes, coding the RANKL and RANK proteins, respectively. The RANKL/RANK axis drives osteoclast differentiation and also plays a role in the immune system. In fact, we have recently reported that mutations in the TNFRSF11A gene lead to osteoclast-poor osteopetrosis associated with hypogammaglobulinemia. Here we present the characterization of five additional unpublished patients from four unrelated families in which we found five novel mutations in the TNFRSF11A gene, including two missense and two nonsense mutations and a single-nucleotide insertion. Immunological investigation in three of them showed that the previously described defect in the B cell compartment was present only in some patients and that its severity seemed to increase with age and the progression of the disease. HSCT performed in all five patients almost completely cured the disease even when carried out in late infancy. Hypercalcemia was the most important posttransplant complication. Overall, our results further underline the heterogeneity of human ARO also deriving from the interplay between bone and the immune system, and highlight the prognostic and therapeutic implications of the molecular diagnosis. © 2012 American Society for Bone and Mineral Research.

AB - Autosomal recessive osteopetrosis (ARO) is a genetically heterogeneous disorder attributed to reduced bone resorption by osteoclasts. Most human AROs are classified as osteoclast rich, but recently two subsets of osteoclast-poor ARO have been recognized as caused by defects in either TNFSF11 or TNFRSF11A genes, coding the RANKL and RANK proteins, respectively. The RANKL/RANK axis drives osteoclast differentiation and also plays a role in the immune system. In fact, we have recently reported that mutations in the TNFRSF11A gene lead to osteoclast-poor osteopetrosis associated with hypogammaglobulinemia. Here we present the characterization of five additional unpublished patients from four unrelated families in which we found five novel mutations in the TNFRSF11A gene, including two missense and two nonsense mutations and a single-nucleotide insertion. Immunological investigation in three of them showed that the previously described defect in the B cell compartment was present only in some patients and that its severity seemed to increase with age and the progression of the disease. HSCT performed in all five patients almost completely cured the disease even when carried out in late infancy. Hypercalcemia was the most important posttransplant complication. Overall, our results further underline the heterogeneity of human ARO also deriving from the interplay between bone and the immune system, and highlight the prognostic and therapeutic implications of the molecular diagnosis. © 2012 American Society for Bone and Mineral Research.

KW - osteoperosis

KW - rank

KW - immune system

KW - transplantaion

KW - hypercalcaemia

U2 - 10.1002/jbmr.559

DO - 10.1002/jbmr.559

M3 - Article

VL - 27

SP - 342

EP - 351

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 2

ER -